Home > Income Statement > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Consolidated Net Profit

    Back to Income Statement
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹3,593 Cr₹-71 Cr₹-203 Cr₹-460 Cr₹268 Cr

What is the latest Consolidated Net Profit of STRIDES PHARMA SCIENCE ?

The latest Consolidated Net Profit ratio of STRIDES PHARMA SCIENCE is ₹3,593 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹3,593 Cr
Mar2024₹-71 Cr
Mar2023₹-203 Cr
Mar2022₹-460 Cr
Mar2021₹268 Cr

How is Consolidated Net Profit of STRIDES PHARMA SCIENCE Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹3,593 Cr
Positive
Mar2024 ₹-71 Cr
Negative
Mar2023 ₹-203 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹268 Cr -

Compare Consolidated Net Profit of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹7,341.0 Cr -8.4% -17.9% 41.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-8.4%

-17.9%

41.6%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses